Status:
COMPLETED
An Integrative Model for Palliative Care in End-Stage Liver Disease
Lead Sponsor:
Virginia Commonwealth University
Conditions:
End Stage Liver DIsease
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this research study is to understand the impact of palliative care in ESLD on quality of life, emergency room or hospital visits, and on care provider burden, and to work to develop the...
Detailed Description
Patients with end-stage liver disease (ESLD) have multiple symptoms that impact their quality of life and result in more emergency room and hospital visits. Palliative care is a medical model that can...
Eligibility Criteria
Inclusion
- Primary participant:
- admission for decompensated cirrhosis, age ≥ 18
- willingness to sign consent
- able to read and understand English
- presence of decompensated cirrhosis with portal hypertension (jaundice, ascites, HE, hepatohydrothorax, AKI, HRS and/or variceal bleeding) or HCC
- Caregiver:
- identified as the primary caregiver of the participant
- age ≥ 18
- willingness to sign consent
- able to read and understand English
Exclusion
- Primary participant:
- prior liver transplant
- lack of capacity to provide informed consent (in the judgement of the investigator)
- already in receipt of palliative or hospice care
- those who are likely to receive a LT during the index admission
- Caregiver:
- • none
Key Trial Info
Start Date :
January 6 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 12 2022
Estimated Enrollment :
28 Patients enrolled
Trial Details
Trial ID
NCT05238779
Start Date
January 6 2022
End Date
December 12 2022
Last Update
July 7 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Virginia Commonwealth University
Richmond, Virginia, United States, 23298